Keros Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $24M | 521k | 45.70 |
| 2024-03-31 | $17M | 258k | 66.20 |
| 2023-12-31 | $8.2M | 205k | 39.76 |
| 2023-09-30 | $3.2M | 100k | 31.88 |
| 2023-06-30 | $3.0M | 74k | 40.18 |
| 2023-03-31 | $2.7M | 62k | 42.70 |
| 2022-12-31 | $7.0M | 146k | 48.02 |
| 2022-06-30 | $4.1M | 148k | 27.64 |
| 2022-03-31 | $7.0M | 128k | 54.38 |
| 2021-12-31 | $7.0M | 119k | 58.51 |
| 2021-09-30 | $2.1M | 52k | 39.57 |
| 2021-03-31 | $392k | 6.4k | 61.62 |
| 2020-12-31 | $8.7M | 124k | 70.54 |
| 2020-09-30 | $683k | 18k | 38.55 |